Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-03-19
2011-10-25
Chu, Yong (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S395000, C514S619000, C548S171000, C548S306400, C564S167000
Reexamination Certificate
active
08044078
ABSTRACT:
The invention relates to a compound of the general formula (I),as defined herein which is useful for the treatment of a pathology in a patient wherein a CCR3 receptor plays a role in the development of the pathology, and pharmaceutical preparations containing such compound. The invention is also directed to a process for preparing the compound of the general formula (I), and intermediate useful in the preparation.
REFERENCES:
patent: 5389630 (1995-02-01), Sato et al.
patent: 6166015 (2000-12-01), Rogers et al.
patent: 6225334 (2001-05-01), Seitz et al.
patent: 2003/0119885 (2003-06-01), Du Bois
patent: 2003/0171413 (2003-09-01), Owen et al.
patent: 2008/0280963 (2008-11-01), Pappne Behr et al.
patent: 2008/0287434 (2008-11-01), Pappne Behr et al.
patent: 19629464 (1998-01-01), None
patent: 220592 (1990-07-01), None
patent: WO 9202487 (1992-02-01), None
patent: WO 9822433 (1998-05-01), None
patent: WO 0053600 (2000-09-01), None
patent: WO 0109088 (2001-02-01), None
patent: WO 0114333 (2001-03-01), None
patent: WO 0187839 (2001-11-01), None
patent: WO 02/59081 (2002-08-01), None
patent: WO 2004004731 (2004-01-01), None
patent: WO 2007034252 (2007-03-01), None
Vippagunta et al., Advanced Drug Delivery Reviews, vol. 48, p. 3-26 ( on p. 3).
Vippagunta et al., Advanced Drug Delivery Reviews, (2001), vol. 48, p. 3-26 ( on p. 3), provided previously.
RN 142196-21-2 (Jul. 3, 1992).
RN 737754-09-5 (2006).
RN 686727-21-9 (Apr. 25, 2003).
RN 371244-71-2 (Nov. 21, 2001).
Aranyi Peter
Bartane Bodor Veronika
Batori Sandor
Kapui Zoltan
Kovacs Marianna
Chu Yong
Sanofi-Aventis
Scully , Scott, Murphy & Presser, P.C.
LandOfFree
Amino-alkyl amide derivatives as CCR3 receptor ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino-alkyl amide derivatives as CCR3 receptor ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino-alkyl amide derivatives as CCR3 receptor ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4261231